{
    "symbol": "AUPH",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-04 12:02:02",
    "content": " As of June 30, 2022, we had cash, cash equivalents and restricted cash and investments of $391.7 million compared to $466.1 million at December 31, 2021. Total net revenue was $28.2 million and $6.6 million for the quarters ended June 30, 2022 and June 30, 2021, respectively. Total revenue was $49.8 million and $7.5 million for the six months ended June 30, 2022 and June 30, 2021. Total cost of sales and operating expenses for the quarter ended June 30, 2022 were $64.2 million in comparison to $53.8 million for the quarter ended June 30, 2021. Total cost of sales and operating expenses for the six months ended June 30, 2022 were $123.7 million in comparison to a $105.2 million for the six months ended June 30, 2021. Cost of sales were $1.6 million and $308,000 for the quarter ended June 30, 2022 and June 30, 2021, respectively. Cost of sales were $1.9 million and $356,000 for the six months ended June 30, 2022 and June 30, 2021. Selling, general and administrative or SG&A expenses inclusive of our share-based compensation were $51.5 million and $44.3 million for the quarters ended June 30, 2022 and June 30, 2021, respectively. SG&A expenses, inclusive of share-based compensation expense, were $96.7 million and $84.1 million for the six months ended June 30, 2022 and June 30, 2021. Non-cash SG&A share-based compensation expense for the quarters ended June 30, 2022 and June 30, 2021 were $8.9 million and $6.5 million, respectively. Non-cash SG&A share-based compensation expense for the six months ended June 30, 2022 and June 30, 2021 was $14.9 million and $13.2 million, respectively. R&D expenses, inclusive of shared-based compensation expense, were $11.5 million and $10.1 million for the three months ended June 30, 2022 and 2021. The six months ended June 30, 2022 and June 30, 2021, R&D expenses inclusive of share-based compensation expense was $24.1 million and $19.9 million. Non-cash R&D share-based compensation expense for the quarters ended June 30, 2022 and June 30, 2021 was $1.1 million for both periods. Non-cash R&D share-based compensation expense for the six months ended June 30, 2022 and June 30, 2021 was $2 million and $2.2 million respectively. For the quarter ended June 30, 2022, Aurinia recorded a net loss of $35.5 million or $0.25 net loss per common share, as compared to a net loss of $47 million or $0.37 net loss per common share for the quarter ended June 30, 2021. For the six months ended June 30, 2022, Aurinia recorded a net loss of $73.1 million or $0.52 net loss per common share, as compared to a net loss of $97.4 million or $0.76 net loss per common share for the six months ended June 30, 2021. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question."
}